Literature DB >> 11470529

Cell toxicity caused by products of the p(L) operon of bacteriophage lambda.

K Sergueev1, D Yu, S Austin, D Court.   

Abstract

Induction of a lambda prophage causes the death of the host cell even in the absence of phage replication and lytic functions due to expression of functions from the lambda p(L) operon. We genetically modified the lambda prophage to determine which lambda p(L) operon functions were involved in cell killing. Viability assays and flow cytometry were used to monitor cell death and filamentation. The kil gene was shown to cause cell death and filamentation as described previously. Another killing activity was mapped within the p(L) operon to the gam gene. Inspection of the DNA sequence showed that there are two possible translation start points for both kil and gam. In both cases, the shorter of the two possible products could cause cell killing. The shorter products were also sufficient for the known filamentation and recombination activities of the respective Kil and Gam functions. The expression level of the p(L) operon is down-regulated by Cro repressor. In the absence of Cro, higher p(L) expression levels allow either Kil or Gam to be lethal or growth inhibitory, whereas at lowered expression in Cro-repressed conditions, only Kil is lethal. The filamentation function of Kil and recombination activity of Gam are unaffected at Cro-repressed levels of expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470529     DOI: 10.1016/s0378-1119(01)00535-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  Regulatory circuit design and evolution using phage lambda.

Authors:  Shota Atsumi; John W Little
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

2.  High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection.

Authors:  Jeroen De Smet; Michael Zimmermann; Maria Kogadeeva; Pieter-Jan Ceyssens; Wesley Vermaelen; Bob Blasdel; Ho Bin Jang; Uwe Sauer; Rob Lavigne
Journal:  ISME J       Date:  2016-02-16       Impact factor: 10.302

Review 3.  Bacteriophage lambda: Early pioneer and still relevant.

Authors:  Sherwood R Casjens; Roger W Hendrix
Journal:  Virology       Date:  2015-03-03       Impact factor: 3.616

4.  Recombineering: a homologous recombination-based method of genetic engineering.

Authors:  Shyam K Sharan; Lynn C Thomason; Sergey G Kuznetsov; Donald L Court
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  Genome of Enterobacteriophage Lula/phi80 and insights into its ability to spread in the laboratory environment.

Authors:  Ella Rotman; Elena Kouzminova; Guy Plunkett; Andrei Kuzminov
Journal:  J Bacteriol       Date:  2012-10-05       Impact factor: 3.490

6.  Conditional lethal amber mutations in essential Escherichia coli genes.

Authors:  Christopher D Herring; Frederick R Blattner
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

Review 7.  Back to BAC: the use of infectious clone technologies for viral mutagenesis.

Authors:  Robyn N Hall; Joanne Meers; Elizabeth Fowler; Timothy Mahony
Journal:  Viruses       Date:  2012-02-03       Impact factor: 5.048

Review 8.  Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.

Authors:  Zuzanna Drulis-Kawa; Grazyna Majkowska-Skrobek; Barbara Maciejewska; Anne-Sophie Delattre; Rob Lavigne
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

9.  Elements in the λ immunity region regulate phage development: beyond the 'Genetic Switch'.

Authors:  Lynn C Thomason; Kathleen Morrill; Gillian Murray; Carolyn Court; Brenda Shafer; Thomas D Schneider; Donald L Court
Journal:  Mol Microbiol       Date:  2019-10-08       Impact factor: 3.979

10.  Use of the lambda Red-recombineering method for genetic engineering of Pantoea ananatis.

Authors:  Joanna I Katashkina; Yoshihiko Hara; Lyubov I Golubeva; Irina G Andreeva; Tatiana M Kuvaeva; Sergey V Mashko
Journal:  BMC Mol Biol       Date:  2009-04-23       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.